Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Strategic CRISPR & Gene Editing Technology ETF

XDNA
Current price
7.38 USD -23.04 USD (-75.74%)
Company
ISIN -
Category Healthcare
Exchange NASDAQ
Capitalization 2 584 623 USD
Yield for 12 month +4.38 %
1Y
3Y
5Y
10Y
15Y
XDNA
21.11.2021 - 28.11.2021

Strategic CRISPR & Gene Editing Technology ETF, a constituent of the ETF, is listed on the NASDAQ. Its market capitalization stands at 2 584 623 USD. Over the past year, it has generated a yield of +4.38 %. The fund's net expense ratio, a critical measure of operational efficiency, is recorded at 0.78 %. A significant allocation in cash assets underscores its liquidity position and risk management strategy. Turning to technical indicators, they offer a granular perspective on the fund's market behavior, historical trends, and potential forward momentum. For an in-depth analysis get premium access.

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

Total Assets

2 584 623 USD

Net Expense Ratio

0.78 %

Annual Holdings Turnover

67 %

Asset HoldingXDNA

Cash

Long 100%
Short -
Net Assets 100%

The US stocks

Long -
Short -
Net Assets -

Stocks ex-US

Long -
Short -
Net Assets -

Bonds

Long -
Short -
Net Assets -

Other

Long -
Short -
Net Assets -

Efficiency XDNA

1y Volatility 37.91%
Returns YTD -25.75%
3y Volatility 0.00%
Returns 1Y -32.72%
3y ExpReturn 0.00%
Returns 3Y 0.00%
3y SharpRatio 0.00%
Returns 5Y 0.00%
Returns 10Y 0.00%

Dividend Analytics XDNA

Dividend growth over 5 years

Continuous growth

Dividend History XDNA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Technical indicators XDNA

For 52 weeks

6.29 USD 7.8 USD
50 Day MA 7.01 USD
200 Day MA 8.43 USD